Lloyd Advisory Services’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.7K Buy
+619
New +$32.2K 0.01% 265
2026
Q1
– Sell
-772
Closed -$29.8K – 1010
2025
Q4
$29.8K Buy
+772
New +$29.4K 0.01% 283

Other funds holding RPRX

Lloyd Advisory Services's RPRX Position: Q2 2026 in Review

Lloyd Advisory Services opened a new position in Royalty Pharma (RPRX) in Q2 2026: 619 shares worth $34.7K. The stake represents 0.01% of the portfolio and ranks #265 among its holdings. This is a return to the name: Lloyd Advisory Services previously reported a position in RPRX as recently as Q4 2025.

Lloyd Advisory Services first reported a position in RPRX in Q4 2025 and has held it in 2 quarters since. 648 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Lloyd Advisory Services held 619 shares of Royalty Pharma worth $34.7K as of Q2 2026.
  • Royalty Pharma was a new Lloyd Advisory Services position in Q2 2026.
  • Royalty Pharma made up 0.01% of Lloyd Advisory Services's portfolio in Q2 2026, its #265 holding.
  • Lloyd Advisory Services first reported a position in Royalty Pharma in Q4 2025 and has held it in 2 quarters since.
  • 648 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.